Join Susannah Streeter and Sarah Coles as they answer your holiday money questions, such as how to pay for your trip, get the best exchange rates and avoid overspending while you’re away. They ...

In this update, Passive Investment Analyst Danielle Farley shares our analysis on the manager, process, culture, ESG Integration, cost and performance of the Vanguard FTSE All-World High Dividend ...

In this update, we look back at key events impacting the stock market, and how the HL Growth Fund performed between 1 April and 30 June 2025, as well as over longer time periods.

In the fund update, Investment Analyst Tom James shares our analysis on the manager, process, culture, ESG integration, cost and performance of the Stewart Investors Asia Pacific Leaders fund.

Novo Nordisk’s first half sales grew 18%, but a slowdown is now expected over the rest of the year.

Tritax has ticked along nicely over the first half, buoyed by rent reviews and the UKCM acquisition.

Diageo delivered better-than-expected set of results, despite a weak underlying alcohol market.

AMD reported strong second-quarter sales growth, but Chinese export restrictions and slightly weak Data Center revenue has weighed on shares.

Eli Lilly has beaten second quarter forecasts, but clinical trial data released on the day has disappointed the market.

Ibstock’s volumes continued to build in the first half, but profitability’s coming under pressure as new capacity gets brought online.

How are some of the UK’s biggest banks performing so far in 2025? Here’s a roundup of Barclays, Lloyds and NatWest's latest results.

Palantir has delivered another knockout quarter, and guidance suggests there’s no signs of things slowing down.